Nasal stimulation device for migraine prevention
Part of Brain & nervous system clinical trials.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 65 years old
- Diagnosed with migraine (with or without aura) or chronic migraine by a doctor
- Migraines started before age 50 and have lasted at least 1 year
- Have at least 8 migraine days per month
- If on migraine prevention medication, dose has been stable for 3 months and willing to maintain it
- Not pregnant, breastfeeding, or planning pregnancy; willing to use birth control if able to have children
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial tests if a device that gently stimulates a nerve on your forehead can safely treat migraines during pregnancy. You'll use the device at home and track your headaches via text or email.
This study tests whether a tailored form of brain stimulation called rTMS can help reduce migraine days. It may be an option for people with frequent migraines who have not changed their preventive medications recently.
This trial tests a new nasal spray, PRT-064040, to see if it can help treat migraine attacks. It is for adults who have had migraines for at least a year and get 2 to 8 moderate to severe migraines per month.
This trial tests whether a computer algorithm can help pick the best migraine prevention medicine for you. You'll try one of several common preventives and track your headaches.
This study tests a new medication called NB001 to help stop migraine headaches when they happen. Researchers want to see if it works better than current treatments for people who have frequent migraines.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.